fda glp-1 news november 2025 The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing GLP-1 Shortage = Over -

GLP-1 supplements work best for individuals with pre-diabetes or mild overweight (BMI 27-32) who want natural support they are not replacements for prescription obesity treatments

The lawyer may perform legal research to understand the current laws about pharmaceutical company liability and how people can seek compensation

Some devices require pinching a fold of skin while others do not

Reddys Laboratories, Johnson & Johnson, LifeScan, Lilly, MSD, Novartis, Novo Nordisk, Roche Diabetes Care India Pvt

Clinically, the results of the injectable and oral formulations are comparable, with the main difference being how the medication enters the bloodstream

These compounded versions arent reviewed by the FDAin fact, the FDA announced Friday that it had asked the Justice Department, out of concern for consumer safety, to investigate Hims & Hers for selling compounded GLP-1 pills